Amarantus Biosci Stock Price, News & Analysis
Company Description
Amarantus Biosci (OTC Link: AMBS) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $315.2K.
AMBS stock has gained 0.0% over the past year. Shares last traded at $0.0000.
This page provides a comprehensive overview of AMBS stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Amarantus Biosci (AMBS) stock last traded at $0.0000. At a market capitalization of $315.2K, AMBS is classified as a micro-cap stock with approximately 630.6M shares outstanding.
Latest News
Amarantus Biosci has 1 recent news article. Of the recent coverage, 1 article coincided with positive price movement and 0 with negative movement. View all AMBS news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
AMBS Company Profile & Sector Positioning
Amarantus Biosci (AMBS) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing AMBS often look at related companies in the same sector, including Havn Life Scienc (HAVLF), Wesana Health Holdings Inc (WSNAF), Altamira Therapeutics Ltd (CYTOF), Bioasis Tech (BIOAF), and Respirerx Pharma (RSPI). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate AMBS's relative position within its industry.